Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/10/20 | Others | Director | 109,372 | 0.1671% | ||
| 13/10/20 | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/10/20 | Tender | General Counsel | 391,686 | 0.5984% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.20% | - | - | 2.27B | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -1.94% | -1.55% | +25.78% | +54.66% | 45.99B | |
| -1.18% | -3.50% | +17.17% | +97.69% | 42.45B | |
| -0.35% | +0.30% | +224.47% | +925.94% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.58% | +3.82% | +51.96% | +162.09% | 43.62B | |
| Weighted average by Cap. | -0.35% | +3.13% | +49.05% | +159.80% |
Employees
-
